Dostarlimab: A breakthrough in the field of oncology

Of the 19 million cancer cases reported worldwide in 2020, colorectal cancer (CRC) has a 10% prevalence and 9.4% mortality. A critical lack of cancer treatment facilities in third-world countries like Pakistan where a significant prevalence of CRC has been detected. The five FDA-approved drugs used...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Hassan ul, Burney, Muhammad Husban, Rehan, Syeda Tayyaba, Hasan, Mohammad Mehedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422050/
https://www.ncbi.nlm.nih.gov/pubmed/36045764
http://dx.doi.org/10.1016/j.amsu.2022.104046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422050/
https://www.ncbi.nlm.nih.gov/pubmed/36045764
http://dx.doi.org/10.1016/j.amsu.2022.104046

Ejemplares similares